You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Last Updated: February 27, 2020

DrugPatentWatch Database Preview

Patent: 9,434,785

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,434,785

Title:	Anti-human OX40L antibodies and methods of treating graft versus host disease with the same
Abstract:	The present invention relates to anti-human OX40L antibodies, new medical uses and methods.
Inventor(s):	Bland-Ward; Philip (Cambridge, GB), Campbell; Jamie (Cambridge, GB), Holmes; Steve (Cambridge, GB), Kirby; Ian (Cambridge, GB), Kosmac; Miha (Cambridge, GB), Kean; Leslie Susan (Seattle, WA), Tkachev; Victor (Seattle, WA)
Assignee:	Kymab Limited (Cambridge, GB)
Application Number:	14/935,937
Patent Claims:	see list of patent claims

Details for Patent 9,434,785

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Genentech	RITUXAN	rituximab	SOLUTION;INTRAVENOUS	103705	001	1997-11-26	Start Trial	Kymab Limited (Cambridge, GB)	2035-09-09	RX		search
Genentech	RITUXAN	rituximab	SOLUTION;INTRAVENOUS	103705	002	1997-11-26	Start Trial	Kymab Limited (Cambridge, GB)	2035-09-09	RX		search
Centocor Inc	REMICADE	infliximab	VIAL	103772	001	1998-08-24	Start Trial	Kymab Limited (Cambridge, GB)	2035-09-09	RX	Orphan	search
Immunex	ENBREL	etanercept	VIAL; SUBCUTANEOUS	103795	001	1998-11-02	Start Trial	Kymab Limited (Cambridge, GB)	2035-09-09	RX	Orphan	search
Immunex	ENBREL	etanercept	SYRINGE	103795	002	1998-11-02	Start Trial	Kymab Limited (Cambridge, GB)	2035-09-09	RX	Orphan	search
Genzyme	CAMPATH	alemtuzumab	VIAL; INTRAVENOUS	103948	001	2001-05-07	Start Trial	Kymab Limited (Cambridge, GB)	2035-09-09	RX	Orphan	search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patent Family for US Patent 9,434,785

Subscribe to access the full database, or Start Trial
Country	Patent Number	Publication Date
Australia	2015225926	Sep 22, 2016
Australia	2016227493	Jun 08, 2017
Brazil	112017015880	Jul 31, 2018
Canada	2941066	Sep 11, 2015
Canada	2968642	Sep 09, 2016
China	106459196	Feb 22, 2017
>Country	>Patent Number	>Publication Date

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Merck

Baxter

McKinsey

Medtronic

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.